We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Osteoporosis and Chronic Obstructive Pulmonary Disease (COPD)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00231127
First Posted: October 4, 2005
Last Update Posted: November 10, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Catharina Ziekenhuis Eindhoven
  Purpose

The goals of the trial are:

  • To determine the prevalence of osteoporosis in subgroups of COPD patients.
  • To look for risk factors of osteoporosis in COPD patients.
  • To create sub-groups for prospective research concerning the effects of bisphosphonates on osteoporosis variables in COPD patients.

Condition
COPD Osteoporosis Osteopenia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Osteoporosis and COPD (Making of a Database)

Resource links provided by NLM:


Further study details as provided by Catharina Ziekenhuis Eindhoven:

Estimated Enrollment: 250
Study Start Date: April 2005
Study Completion Date: January 2009
Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
Detailed Description:

Background:

Osteoporosis is defined as a systemically skeletal disorder characterized by a low bone mass and deterioration of the micro-architecture of the bone and is therefore associated with a higher risk of fractures. Large epidemiological studies to determine the incidence and prevalence of osteoporosis in COPD patients in different stages of their disease are not available. The etiology of osteoporosis in COPD patients is complex and depends on multiple factors.

Goals of the Trial:

  • To determine the prevalence of osteoporosis in subgroups of COPD patients.
  • To look for risk factors of osteoporosis in COPD patients.
  • To create sub-groups for prospective research concerning the effects of bisphosphonates on osteoporosis variables in COPD patients.

Study Design:

Patients diagnosed with COPD (according to the American Thoracic Society [ATS] guidelines and divided in stages according to the Global Initiative on Obstructive Lung Diseases [GOLD]-classification) who visit the out-patient clinic of pulmonology of the Catharina Hospital Eindhoven will be asked to participate in the trial. A database will be created (prospectively) of the (medical) information about these patients, which will be analysed retrospective. To gather information we will use the medical records, a questionnaire, a blood sample, long function testing including a 6-minute walking test and a DEXA-scan.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Chronic Obstructive Pulmonary Disease Patients visiting the pulmonary outpatient clinic of the Catharina Hospital Eindhoven.
Criteria

Inclusion Criteria:

  • Age > 18 years
  • Men and women
  • COPD according to the ATS-guidelines, divided in severity according to the GOLD criteria
  • Written consent

Exclusion Criteria:

  • Age < 18 years
  • No written consent
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00231127


Locations
Netherlands
Catharina Hospital Eindhoven
Eindhoven, Noord-Brabant, Netherlands, 5602 ZA
Sponsors and Collaborators
Catharina Ziekenhuis Eindhoven
Investigators
Principal Investigator: Lidwien Graat, MD Catharina Hospital Eindhoven (Department of Pulmonology)
  More Information

Responsible Party: Lidwien Graat-Verboom/MD (principal investigator), Catharina Hospital Eindhoven
ClinicalTrials.gov Identifier: NCT00231127     History of Changes
Other Study ID Numbers: M05-1522
First Submitted: October 3, 2005
First Posted: October 4, 2005
Last Update Posted: November 10, 2009
Last Verified: November 2009

Keywords provided by Catharina Ziekenhuis Eindhoven:
COPD
Osteoporosis
Osteopenia
Glucocorticoids
GOLD
BODE

Additional relevant MeSH terms:
Pulmonary Disease, Chronic Obstructive
Osteoporosis
Bone Diseases, Metabolic
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Diseases
Bone Diseases
Musculoskeletal Diseases
Metabolic Diseases